सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Hyderabad paediatrician who pushed ORS labelling reforms served legal notice by pharma firms

GS2Polity · Governance · IR· Health policy & public health· Mains·

Why in news

Pharmaceutical companies served a legal notice to Dr. Sivaranjani Santosh for allegedly making defamatory statements regarding ORS products following FSSAI's October 2025 labelling order.

Background

The FSSAI issued an order in October 2025 requiring brands to use the term 'Oral Rehydration Salts' or 'ORS' only if formulations adhere to WHO standards. Dr. Santosh, a Hyderabad-based paediatrician, is challenging the compliance of certain products based on this directive.

Facts for Prelims

  • BodyFSSAI: Food Safety and Standards Authority of India
  • FactFSSAI order (October 2025): ORS labelling permitted only for formulations adhering to WHO standards
  • PlaceHyderabad: Location of Dr. Sivaranjani Santosh's practice

For Mains

Q. Discuss the importance of standardized labelling and regulatory oversight in ensuring the safety of essential medicines and health products in India.

Dimensions to cover in your answer

  • Regulatory oversight: Ensuring pharmaceutical compliance with WHO standards to prevent public health risks
  • Consumer protection: Balancing corporate freedom of speech against the right to accurate health information
  • Standardization gap: Challenges in monitoring diverse private-label formulations under FSSAI guidelines

Keywords: Regulatory Compliance · Public Health Safety · Standardization · Consumer Protection · Pharmaceutical Oversight

Read the full news →Source: The Hindu ↗Also: GS3 · Biotechnology & health research

More Social Justice notes

All Social Justice current affairs →

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.